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Abstract
Objective This study aimed to evaluate the effects of a porcine
acellular dermal matrix (PADM) with or without an enamel
matrix derivative (EMD) on gingival recession defects treated
with a coronally advanced flap (CAF) in dogs.
Materials and methods Miller class II gingival recession de-
fects (5 mm wide and 7 mm deep) were surgically created on
the labial side of bilateral maxillary canines in 12 dogs. After
8 weeks of plaque accumulation, the 24 chronic defects were
randomly assigned to one of the following 4 treatments: CAF,
CAF with PADM (CAF/PADM), CAF with EMD (CAF/
EMD), and CAF with EMD and PADM (CAF/EMD/
PADM). The animals were sacrificed 10 weeks after surgery
for histologic evaluation.
Results In all groups, root coverage was obtained to a varying
degree. PADM was well incorporated in gingival connective
tissue in the CAF/PADM and in the CAF/EMD/PADM
groups. The height of newly formed bone was significantly
greater in the CAF/EMD/PADM group than in the CAF and
CAF/PADM groups. New cementum with periodontal
ligament-like tissue was predominantly found in the CAF/
EMD and CAF/EMD/PADM groups. The CAF/EMD/
PADM group showed the greatest amount of new cementum
among the groups examined, although the difference was not
statistically significant.
Conclusion Within the limitations of the present study, it can
be concluded that CAF/EMD/PADM treatment may promote
periodontal regeneration in gingival recession defects.
Clinical relevance The present results suggest that the combi-
nation of EMD and PADM in conjunction with CAF may
represent a promising approach for treating single Miller class
II gingival recessions.
Keywords Root coverage . Gingival recession defects .
Porcine acellular dermal matrix . Enamel matrix derivative .
Periodontal regeneration . Animal study
Introduction
Gingival recession causes many problems such as impaired
aesthetics, plaque accumulation, and subsequent gingivitis
and/or root caries or dentin hypersensitivity [1, 2]. A variety
of surgical techniques has been developed to predictably ob-
tain complete root coverage of gingival recession defects [3].
Clinically, the subepithelial connective tissue graft (CTG) in
conjunction with a coronally advanced flap (CAF) is consid-
ered to be the gold standard due to its favorable outcomes for
root coverage [2, 3]. However, major shortcomings of harvest-
ing CTG are patient morbidity associated with the second
surgical site and surgical time, as well as the limited supply
of donor tissue especially for treating multiple recession de-
fects [4, 5]. Thus, the acellular dermal matrix (ADM) allograft
has been introduced to overcome these drawbacks [6].
Histological and clinical studies have shown that ADM and
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CTG may result in comparable outcomes when used in con-
junction with CAF for recession coverage [6–9]. It has been
reported that healing following ADM placement is character-
ized by minimal creeping attachment, connective tissue adhe-
sion, and limited blood supply for graft integration [10–12].
Moreover, due to its human origin and the potential risk of
disease transmission or psychological aspects, the ADM is
still controversially discussed in some countries [13]. In order
to overcome the drawbacks related to the use of human ca-
daveric dermal tissues, various types of collagen matrices
have been introduced. Very recent preclinical and clinical
studies have provided evidence for the effectiveness of a
porcine-derived collagen matrix in the treatment of single or
multiple gingival recessions [5, 14–19]. Further studies have
shown that a porcine-derived acellular dermal collagen matrix
(PADM: Mucoderm®, Botiss Dental, Berlin, Germany) can
promote growth and proliferation of human gingival fibro-
blasts, osteoblasts, and endothelial cells in vitro, while
in vivo findings have revealed that PADM is capable of sig-
nificant revascularization of its collagen structure during the
early healing period [13, 20, 21].
The ultimate goal of root coverage treatment is not
only to cover the gingival defects but also to regenerate
periodontal supporting apparatus (cementum, periodontal
ligament, and alveolar bone) for maintaining the obtain-
ed gingival height and width. Enamel matrix derivative
(EMD) was first documented in the periodontal litera-
ture in 1997 as a tissue healing modulator to mimic
events that occur during root development. It is an ef-
fective agent for stimulating periodontal regeneration
with formation of a new acellular extrinsic fiber cemen-
tum, which firmly attaches to the denuded root surface
[22, 23]. Moreover, it has recently been demonstrated
that EMD has a positive influence on the increase in
gingival thickness in dehiscence-type defects in dogs
[24]. These results might propose a new rationale for
the increased predictability of CAF in achieving com-
plete root coverage when EMD and/or PADM is used
adjunctively.
Therefore, the present study aimed to evaluate the effects of
a PADM with or without EMD on gingival recession defects
treated with CAF in dogs.
Method and materials
Animals
Twelve healthy male Beagle dogs, 11 to 15 months old,
weighting 10.3 to 14.4 kg, were used in this study. The pro-
cedures and protocol design described here were approved by
the ethical committee of the Animal Research Center of
Kagoshima University, Japan (MD13164).
EMD
Emdogain®-Gel (Straumann, Basel, Switzerland), a premixed
ready-to-use heat-treated Emdogain® dissolved in a propylene
glycol alginate (PGA) solution, was used.
PADM
Porcine acellular dermal matrix (PADM: Mucoderm®, Botiss
Dental, Berlin, Germany) is a collagen tissue matrix derived
from porcine dermis that passes through a multi-step cleaning
process which removes all antigenic components from the
dermis. This results in a three-dimensional stable matrix
consisting of type I/III collagen and elastin.
Surgical protocol
One surgeon (Y.S.) performed all surgical procedures un-
der general and local anesthesia using aseptic routines.
General anesthesia was achieved using sodium pentobar-
bital (0.4 ml/kg IV; Somunopenchiru, Kyoritsu Seiyaku,
Tokyo, Japan) maintaining spontaneous breathing. Local
anesthesia was performed using lidocaine HCl/
epinephrine (2 %, 1:80,000; Xylocaine). Dehiscence-
type gingival recession defects were surgically created
bilaterally in the maxillary canines. Two vertical inci-
sions separated by a distance of 5 mm were made from
the gingival margin and extending 7 mm apically. These
incisions were connected apically by a horizontal inci-
sion and coronally by an intrasulcular incision. The gin-
gival tissue limited by the incisions was removed using a
periosteal elevator. The exposed bone was removed by
hand instruments and the root surface instrumented to
remove the cementum. A coronal notch extending
5 mm in the mesio-distal direction was placed on the
root surface at the level of the cemento-enamel junction
(CEJ). The created defects were exposed for a period of
8 weeks to plaque accumulation (Fig. 1a). After 8 weeks
of plaque accumulation, scaling and root planing were
performed. A regimen of plaque control using a 2 %
solution of chlorhexidine gluconate was instituted for
14 days prior to the reconstructive surgeries. Full-
thickness flaps were then raised; the root surfaces were
once again scaled. Additional reference notches were
made using a #1 round bur on the root surface at the
base of the defects, and on the crown surface to indicate
the precise center plane of the dehiscence defects and to
aid in optimal histologic processing (Fig. 1b). Each of
the contralateral defects in each animal was then random-
ly assigned to one of the following treatments: CAF
alone, CAF with EMD (CAF/EMD), CAF with PADM
placement (CAF/PADM), and their combination (CAF/
EMD/PADM). In the CAF/PADM group, PADM was
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mixed with the animal’s fresh blood for 10 min before
being applied to the defect. Defect root surfaces that
received EMD were conditioned with a 24 % EDTA
gel (PrefGel®, Straumann AG, Basel, Switzerland) for
2 min and then, along with the adjacent mucoperiosteal
flaps, thoroughly rinsed with sterile saline. The EMD gel
was applied to the root surfaces, and the defects were
filled up to the adjacent alveolar crest (Fig. 1c). Prior
to the placement of EMD/PADM, the PADM was
trimmed and fully saturated with the EMD gel and the
construct was allowed to rest for 10 min. The construct
(EMD/PADM) was placed over the denuded root sur-
faces. The PADM was fixed to the residual periosteum
using resorbable 5-0 sutures to cover the gingival reces-
sion defects completely (Fig. 1d). A periosteal releasing
incision was made, and the reflected gingival flaps were
coronally advanced to the pretreatment position,
attempting to fully cover the defects and/or PADM, and
sutured using monofilament suture material (Gore-Tex
CV-6 Suture) (Fig. 1e).
The animals were fed a soft diet for 2 weeks. An analgesic
of buprenorphine HCl (0.1 ml/kg IM; Lepetan) and an antibi-
otic (Procaine penicillin G, 200,000 units IM) were adminis-
tered daily for 3 days. Plaque control was maintained by rou-
tine flushing (three times a week) of the oral cavity with a
chlorhexidine solution (chlorhexidine gluconate; 25 ml of a
2 % solution) for 10 weeks postsurgery. The sutures were
removed 2 weeks after surgery.
Histologic and histometric analyses
Ten weeks after surgery, the animals were euthanized by
an overdose injection of sodium pentobarbital. All the
defects were dissected along with the surrounding soft
and hard tissues. The tissue blocks were fixed in 10 %
buffered formalin and trimmed. The samples were
dehydrated and embedded in polyester resin. The resin
blocks were cut bucco-lingually to a thickness of 100 to
150 μm with a low-speed diamond saw. Slides were
ground and polished to a final thickness of 35 to
45 μm using a microgrinding system with non-adhesive
abrasive discs and stained with toluidine blue. All the
specimens were analyzed histometrically under a light
microscope (BX51, Olympus Optical Co., LTD, Tokyo,
Japan) equipped with a computerized image system (Win
Roof Version 6.0, Mitani Corporation, Fukui, Japan). For
histometric analysis, two sections were selected from the
most central area of each gingival recession defect, iden-
tified by the coronal and apical notches on the root and
the reference notch on the crown. The mean value of
each histometric parameter was calculated for each site.
Fig. 1 Clinical overview. a
Fabricated dehiscence type of
gingival recession defect after
8 weeks of plaque accumulation.
b Defect on the root after flap
elevation. c EMD was applied
onto the denuded root surface
after root conditioning. d PADM
was placed to cover the entire
defect and the adjacent bone and
sutured. e A coronally advanced
flap totally covered the PADM. f
At 10 weeks after root coverage
of canine treated by CAF with
EMD and PADM. Healing was
uneventful
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The following parameters were measured by the same
experienced and masked examiner (N.T.):
1 Gingival recession (GR)—distance from the gingival mar-
gin to the coronal notch (CEJ) at the sites where the gin-
gival margin was located apically to the coronal notch.
Negative values were assigned to these measurements. If
the gingival margin was located at the level of the coronal
notch or coronal to this notch, a B0^ value was applied.
2 Epithelial length (EL)—distance between the apical extent
of junctional epithelium and the coronal notch when the
gingival margin was coronal to the coronal notch. If gin-
gival recession was present, this measurement was record-
ed from the gingival margin to the apical extent of junc-
tional epithelium.
3 Connective tissue adaptation (CT; without cementum)—
distance between the apical extent of junctional epithelium
and coronal extent of newly formed cementum.
4 New cementum formation (NC)—distance between the
apical extent of root planing and the coronal extent of
newly formed cementum on denuded root surface.
5 New bone formation (NB)—distance between the apical
extent of root planing and the coronal extent of newly
formed alveolar bone.
6 Soft tissue thickness (STT)—distance from the buccal out-
ermost gingival/mucosal surface to the tooth surface at
three different levels:
(a) STT-1—at the top of the coronal notch (CEJ)
(b) STT-2—at the middle between the coronal and apical
notches
(c) STT-3—at the base of the apical notch (defect)
7 Soft tissue height (STH)—distance between the apical ex-
tent of root planing and the gingival margin.
8 Defect height (DH)—distance between the apical notch
and the coronal notch.
Forty-eight sections from all sites were read by the exam-
iner without calibration before the measurements. Forty-eight
hours later, the same examiner read all 48 sections again to
evaluate intra-examiner reproducibility. Inter-calibration of
the examiner was accepted at the 90 % level.
Statistical analysis
Mean values for each histometric parameter were obtained
per defect. The mean values for all groups were deter-
mined using the individual means from the 12 animals.
The hypothesis that there were no differences among the
groups was tested by analysis of variance. If a statistical
difference was detected, a post hoc test was used for mul-
tiple comparisons. A p value of <0.05 was considered
statistically significant. All calculations were performed
using a statistical software program (SPSS Statistics
Version 20, IBM, Armonk, NY, USA).
Results
Clinical observations
Root coverage was obtained to a varying degree in this chron-
ic gingival recession model. Basically, the gingival margin
was located approximately at the CEJ in all sites. Residual
gingival recessions (the gingival margin was located below
the CEJ) were found in four sites in the CAF group, two sites
in the CAF/EMD group, and one site in the CAF/PADM and
CAF/EMD/PADM groups. One site in the CAF/EMD/PADM
group was excluded from histologic and histometric analyses
because of severe dehiscence of the flap with considerable
PADM exposure due to physical contact of the lower canine
3 days after surgery. The rest of the five sites in the CAF/
EMD/PADM group exhibited favorable clinical healing with-
out any complications (Fig. 1f).
Histologic observations
In the CAF group, slight gingival recession remained in
most of the specimens (four sites) (Fig. 2a). The amount
of new bone was minimal and new cementum formation
was very limited above the apical notch in a few speci-
mens. Periodontal regeneration was not observed in most
of the specimens, and connective tissue fibers were
aligned parallel to the root surface (Fig. 2a, b). In the
CAF/PADM group, the residual gingival recession was
detected only in one site, and the amounts of soft tissue
height and soft tissue thickness were greater compared to
those of the CAF group (Fig. 3a). In general, the healing
pattern regarding new bone and orientation of collagen
fibers in the CAF/PADM group was similar to that in
the CAF group. However, a thin continuous layer of
new acellular extrinsic fiber cementum was predominant-
ly detected on the previously denuded and contaminated
root surface in four sites (Fig. 3b). In the PADM-applied
groups (CAF/PADM, CAF/EMD/PADM), remnants of the
PADM were found to varying degrees and they were
completely integrated with the adjacent connective tissue
with no signs of encapsulation, multinucleated giant cells,
or granulation tissue (Figs.3b and 6a, b).
New bone was observed coronally to the apical notches
in most of the specimens (five sites) in the CAF/EMD and
CAF/EMD/PADM groups. Moreover, a thin continuous
layer of a blend of new cellular, intrinsic, or mixed fiber
cementum was mostly found at the apical portion and
tended to change to acellular extrinsic fiber cementum at
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the coronal portion on the denuded root surface in these
EMD-applied groups (Figs. 4, 5, and 6). Dense collagen
fibers were seen inserting into the newly formed cemen-
tum, oriented oblique to the root surface (Figs. 4b and 6a,
b). However, bone formation was more pronounced in the
CAF/EMD/PADM group than in the CAF/EMD group
(Fig. 5). There was no extensive root resorption or anky-
losis, irrespective of the treatment group.
Histometric analysis
The results of the histometric analysis are summarized in
Table 1. No statistically significant differences were detect-
ed among the groups in regard to the following measure-
ments: GR, EL, CT, STT-3, and DH. New cementum
formation with continuous periodontal ligament-like tissue
was most notable in the CAF/EMD/PADM group among
the groups examined, although the difference was not sta-
tistically significant. More cementum was also found in the
CAF/EMD group compared to both the CAF and CAF/
PADM groups, although without statistically significant dif-
ferences. New bone formation in the CAF/EMD/PADM
group was significantly greater than in the CAF and
CAF/PADM groups. In the CAF/EMD/PADM group, soft
tissue thickness at the top of the notch was significantly
greater than that in the CAF group. Moreover, soft tissue
thickness at the middle between the coronal and apical
notches was significantly greater in the CAF/EMD/PADM
group than in both the CAF and CAF/PADM groups. For
soft tissue height, there were no significant differences
Fig. 2 Representative
photomicrographs of a gingival
recession defect treated by CAF. a
Overview of the defect (scale bar,
1 mm; toluidine blue staining). b
Higher magnification of the notch
area (scale bar, 200 μm; toluidine
blue staining). CEJ cemento-
enamel junction, GM gingival
margin, D root dentin, JE apical
end of junctional epithelium, N
apical end of apical notch
Fig. 3 Representative
photomicrographs of a gingival
recession defect treated by CAF
with PADM. a Overview of the
defect (scale bar, 1 mm; toluidine
blue staining). b Higher
magnification of the middle
portion of the defect (scale bar,
200 μm; toluidine blue staining).
CEJ cemento-enamel junction,
GM gingival margin, D root
dentin, JE apical end of junctional
epithelium, N apical end of apical
notch, NC new cementum, *
remnants of PADM. Fiber
bundles of the PADM were
dispersed and surrounded by
connective tissue
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among the groups. Nevertheless, the CAF group showed
the smallest height and the CAF/EMD/PADM group
showed the greatest height. No significant differences in
any of the histometric parameters were observed between
the CAF/EMD and CAF/EMD/PADM groups.
Discussion
To the best of our knowledge, no preclinical study has yet
evaluated the outcomes of a CAF, CAF with PADM
(Mucoderm®), and/or EMD for the treatment of gingival re-
cessions. The present study shows that CAF/EMD/PADM
resulted to a greater extent in periodontal regeneration than
the other treatment groups. The amount of newly formed ce-
mentum was greater in the EMD-applied groups (CAF/EMD
and CAF/EMD/PADM) than in the CAF and CAF/PADM
groups. These findings are in agreement with previous reports
demonstrating that EMD deposition on the root surfaces po-
tently affects cementum formation [22, 25]. Moreover, dense
collagen fibers inserted into the newly formed cementumwere
oriented obliquely to the root surface. Highly vascularized
new periodontal ligament-like tissue was found only in the
area between new cementum and new bone in the EMD-
applied groups. These findings are similar to those of previous
studies evaluating the effect of EMD on the healing of various
periodontal defects [22–27]. These results may be explained
by the report that EMD significantly promotes both periodon-
tal ligament and bone cell attachment [28], and stimulates
angiogenesis directly through endothelial cells and indirectly
through production of vascular endothelial growth factor by
periodontal ligament cells [29, 30].
In this chronic dehiscence defect model, the buccal alveolar
bone plate was very thin (generally <1 mm) at the reconstruc-
tive surgery due to bone resorption. It has been reported that
the space between the flap and the root surface was minimal
resulting in the small amounts of newly formed bone or root
resorption following root coverage treatments using guided
tissue regeneration, EMD, ADM, CTG, or platelet-rich plas-
ma [31–35]. The amount of new bone obtained in the present
study was comparable to that of previous reports. However,
Fig. 4 Representative
photomicrographs of a gingival
recession defect treated by CAF
with EMD. a Overview of the
defect (scale bar, 1 mm; toluidine
blue staining). b Higher
magnification of the notch area
(scale bar, 200 μm; toluidine blue
staining). CEJ cemento-enamel
junction, GM gingival margin, D
root dentin, JE apical end of
junctional epithelium, N apical
end of apical notch,NB new bone,
NC new cementum, PDL
periodontal ligament
Fig. 5 Representative photomicrograph of a gingival recession defect
treated by CAF with EMD and PADM. Overview of the defect (scale
bar, 1 mm; toluidine blue staining). CEJ cemento-enamel junction, GM
gingival margin, D root dentin, JE apical end of junctional epithelium, N
apical end of apical notch, NB new bone, NC new cementum
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the CAF/EMD/PADM group induced significantly greater
bone formation with narrow bone growth along the root sur-
face compared to the CAF and CAF/PADM groups. The re-
sults are supported by the findings that new bone formation
occurs moderately along the root surface following acellular
cementum and periodontal ligament formation [25, 27, 36],
and indicate that EMD improved bone formation in gingival
recession defects treated byCAF or CAF/PADM. Sallum et al.
reported that the extent of new bone and new cementum was
greater with CAF/EMD treatment than with CAF treatment
alone, although the differences were not statistically signifi-
cant [32]. Moreover, an earlier study demonstrated that the
amounts of new cementum and new bone at the sites of gin-
gival recession were significantly greater after CAF with
EMD and GTR treatment than those after CAF and GTR or
CAF treatment [37]. These results indicate that EMD has ad-
junctive biological effects on the formation of both new ce-
mentum and new bone and PADMmay act as a biocompatible
barrier membrane to provide sufficient space maintaining its
three-dimensional structure for cell migration and growth [13,
20], blood clot stabilization [38, 39] as well as new tissue
formation in this type of dehiscence defects. However, it
might be necessary to compare CAF/EMD/PADM and CAF/
EMD/GTR in the same type of defects to investigate whether
PADM has indeed an additional role as a barrier membrane.
In contrast, de Oliveira et al. demonstrated that EMD did
not result in beneficial effects regarding new cementum and
new bone when combined with ADM compared to ADM
alone [33]. The discrepancy in bone and cementum formation
between our study and the study by de Oliveira et al. [33] may
Table 1 Histomorphometric parameters for each surgical treatment (mean ± SD; mm)
Surgical treatment Statistically
significant
differences(1) CAF (2) CAF/EMD (3) CAF/PADM (4) CAF/EMD/
PADM
n = 6 n = 6 n = 6 n = 5
GR −0.55 ± 0.62 −0.07 ± 0.11 −0.09 ± 0.21 −0.15 ± 0.34 NS
EL 2.79 ± 0.62 2.31 ± 0.95 2.15 ± 1.33 2.16 ± 0.92 NS
CT 0.45 ± 0.74 0.60 ± 0.99 0.66 ± 1.08 0.42 ± 0.41 NS
NC 1.05 ± 1.03 1.92 ± 1.33 1.50 ± 1.54 2.57 ± 1.32 NS
NB 0.06 ± 0.14 0.53 ± 0.38 0.12 ± 0.30 1.06 ± 0.90 1 vs 4, 3 vs 4
STT-1 0.13 ± 0.31 0.65 ± 0.53 0.61 ± 0.32 0.86 ± 0.51 1 vs 4
STT-2 1.24 ± 0.58 2.63 ± 1.42 2.01 ± 1.45 3.91 ± 0.56 1 vs 4, 3 vs 4
STT-3 3.15 ± 0.54 3.79 ± 0.85 3.59 ± 1.19 4.41 ± 0.60 NS
STH 4.39 ± 0.90 5.59 ± 1.07 5.22 ± 0.36 5.85 ± 1.69 NS
DH 5.75 ± 0.15 5.73 ± 0.52 5.69 ± 0.44 5.62 ± 0.77 NS
NS not significant
Fig. 6 a Higher magnification of
the middle portion of newly
formed bone seen in Fig. 5 (scale
bar, 200 μm; toluidine blue
staining). b Higher magnification
of the coronal extent of newly
formed bone seen in Fig. 5 (scale
bar, 200 μm; toluidine blue
staining). CEJ cemento-enamel
junction, D root dentin, JE
junctional epithelium, N apical
notch, NB new bone, NC new
cementum, PDL periodontal
ligament, * remnants of PADM
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be attributed to the differences in types or thickness of the flap,
wound stability, volume, structural component of the mate-
rials (between Mucoderm® and Alloderm®), and coating con-
ditions of EMD [33, 39–41]. The interaction between the bio-
materials and EMD is a primary determining factor influenc-
ing downstream cellular behavior and subsequent periodontal
regeneration [41–43]. In this regard, PADM used in this study
might act as a suitable carrier for EMD. However, the binding
and release kinetics could not be examined in the present
study since in vitro experiments are necessary for this.
Further investigations are therefore needed to clarify this
issue.
In the present study, PADM demonstrated good bio-
compatibility, which might support its rapid revasculari-
zation [13, 20], and PADM was completely incorporated
into surrounding gingival connective tissue without
impairing the healing process. Rothamel et al. observed
that native dermal non-cross-linked type I/III collagen
(Mucoderm® prototype) was almost completely resorbed
after 12 weeks in a subcutaneous rat model, and displayed
a faster tissue integration and vascularization with no
signs of ingrowing inflammatory cells than chemically
cross-linked collagen [21]. These findings may be sup-
ported by the report that types I, II, and III collagens
and collagen-degradation peptides might function as che-
motactic stimuli for fibroblasts in vivo and attract these
cells to the site of tissue damage [44]. Moreover, STT and
STH were greater in the PADM-applied groups than in the
CAF group. The results indicate that PADM may increase
and maintain the volume of soft tissue in root coverage
treatment [16, 19]. Interestingly, there were no statistically
significant differences in STT and STH between the CAF/
PADM and the CAF/EMD groups, and the amounts of
STT and STH in the CAF/EMD group were superior to
those of the CAF group. These findings are in agreement
with the observation that EMD has a positive influence on
the increase in gingival thickness in dehiscence-type de-
fects in dogs [24]. Furthermore, these findings are sup-
ported by in vitro studies showing that EMD stimulated
the proliferation of gingival fibroblasts [45, 46], protected
gingival fibroblasts from tumor necrosis factor-induced
apoptosis [47], and increased extracellular matrix protein
production [48] and the level of TGF-β, which has been
reported to facilitate tissue repair and regeneration [49,
50], in gingival and periodontal ligament fibroblasts [51,
52]. Thus, these effects of EMD might enhance the
proliferative/maturation phase of soft tissue wound
healing [30, 49].
Compared with those of the CAF/EMD group, the amounts
of NC, NB, STT, and STH were higher in the CAF/EMD/
PADM group, although not statistically significant. Thus,
one plausible explanation for the most favorable results in
the CAF/EMD/PADM group may be attributable to the
aforementioned positive effects of PADM and EMD in this
defect model.
However, due to the small number of teeth treated, the
obtained results in the present animal study should be
interpreted cautiously. Further clinical studies with large sam-
ple size including benchmark CAF/CTG treatment are neces-
sary to verify the effects of CAF/EMD/PADM treatment on
periodontal healing in the treatment of human gingival reces-
sion defects.
Conclusion and clinical relevance
Within the limitations of the present study, it can be concluded
that the combination of CAF/EMD/PADMmay promote peri-
odontal regeneration and points to its potential relevance in
the treatment of single Miller class II gingival recessions.
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